EDGAR Filing Documents for 0001144204-16-100528

Form 8-K - Current report:

SEC Accession No. 0001144204-16-100528

Filing Date

2016-05-10

Accepted

2016-05-10 17:05:18

Documents

Period of Report

2016-05-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v439455_8k.htm	8-K	35006
2	EXHIBIT 3.3	v439455_ex3-3.htm	EX-3.3	36656
3	EXHIBIT 10.1	v439455_ex10-1.htm	EX-10.1	19008
4	EXHIBIT 10.2	v439455_ex10-2.htm	EX-10.2	148474
5	EXHIBIT 10.3	v439455_ex10-3.htm	EX-10.3	95359
6	EXHIBIT 10.4	v439455_ex10-4.htm	EX-10.4	42315
	Complete submission text file	0001144204-16-100528.txt		378769

Mailing Address 207A PERRY PARKWAY, SUITE 1 GAITHERSBURG, MD 20877

Business Address 207A PERRY PARKWAY, SUITE 1 GAITHERSBURG, MD 20877 240-499-2680

Nuo Therapeutics, Inc. (Filer) CIK: 0001091596 (see all company filings)